Cetuximab

Cetuximab is used for: Treating certain types of head, neck, and colorectal cancer. This medicine may be used alone or along with radiation treatments or other medicines. It may also be used for other conditions as determined by your doctor

Brands
ERBITUX
Adult Dose
Neonatal
Paedriatic
Characteristics
It belongs to Chimeric Monoclonal antibody pharmacological group on the basis of mechanism of action.
Contraindications
Cetuximab
Effects
Cetuximab produces potentially life-threatening effects which include Cardiopulmonary arrest, Hypomagnesemia, Hypotension/hypertension. which are responsible for the discontinuation of Cetuximab therapy.The symptomatic adverse reactions produced by Cetuximab are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Anorexia, Diarrhea, Fever, Dyspnea, Skin reactions, Constipation, Asthenia, Acneform rash.
Indications
Cetuximab is primarily indicated in conditions like Metastatic colorectal cancer, Squamous cell carcinoma of head, Squamous cell carcinoma of neck.
Interactions
No data regarding the interactions of Cetuximab was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Monitoring for signs of infusion reaction during and for 1 hour following each infusion in setting where resuscitation equipment and agent to anaphlaxis is readily available. Avoid inhalation,skin and eye contant. Should be given with caution to head and neck cancer with coronory artery disease.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.